{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001037846.5:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_001037846.5",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant in LRRK2 gene"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005172"
  },
  "Experiment Method": [
    {
      "Assay Method": "Case-Control Study",
      "Material used": {
        "Material Source": "Human subjects",
        "Material Name": "Patients with Parkinson's disease and healthy controls",
        "Description": "The study included 524 patients with Parkinson's disease and 1020 controls. A meta-analysis combined this cohort with 14 other studies (3418 cases and 3452 controls)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001037846.5:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased risk of Parkinson's disease",
          "Result Description": "The LRRK2 G2019S variant showed a significant association with Parkinson's disease risk (OR=2.06, P=0.0003) in the case-control study. The meta-analysis confirmed this association (P=2.2×10⁻⁶)."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Odds ratio (OR) calculation and meta-analysis using fixed-effect model."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "P-value ≥ 0.05 (standard for statistical significance in case-control studies).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "P-value < 0.05 (statistically significant association with disease).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}